Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study
The Lancet Microbe · 2025
DOI: 10.1016/j.lanmic.2025.101188 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift The Lancet Microbe, 2025. Verfasst von Allison R Smither und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA; Galveston National Laboratory, University of T…. Hauptthemen laut MEDLINE: Antibodies, Viral, Lassa virus, Lassa Fever, Antigens, Viral. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases Division of Intramural Research, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
BACKGROUND: Lassa fever, caused by Lassa mammarenavirus (LASV), is a rodent-borne disease endemic to west Africa. Zoonotic surveillance of LASV provides epidemiological insights into its potential presence. We aimed to assess LASV antigen and antibody prevalence in peri-domestic rodents in southeastern Sierra Leone. METHODS: In this cross-sectional study, small mammal trapping was conducted in Kenema District, Sierra Leone, from Nov 8, 2018 to July 10, 2019. LASV antigen was detected with a nucleoprotein antigen rapid diagnostic test at necropsy, then compared with gold-standard quantitative RT-PCR in a subset of specimens to assess specificity and sensitivity. LASV IgG antibodies against nucleoprotein and glycoprotein were tested using a semi-quantitative ELISA in Mastomys and Rattus species. FINDINGS: Of the 373 specimens tested, 74 (20%) were positive for LASV antigen. Compared with qRT-PCR, antigen testing showed a specificity of 61·9% (95% CI 52·5-70·6) and sensitivity of 100·0% (95% CI 2·5-100·0%). 40 (11%) specimens tested positive for LASV nucleoprotein-specific IgG, whereas an additional 12 (3%) were only positive for LASV glycoprotein-specific IgG, respectively. Simultaneous antigen and IgG antibody presence was observed in some Mastomys sp specimens (odds ratio 0·43 [95% CI 0·24-0·73], p=0·0011). However, the relative strength of antigen response did not explain the variability in the IgG response to either glycoprotein (ρ 0·04 [95% CI -0·34 to 0·41], p=0·85) or nucleoprotein (ρ -0·23 [95% CI -0·52 to 0·11], p=0·17). INTERPRETATION: Although further evaluation is needed, the tools used in this study can aid in generating valuable public health data for LASV surveillance and in prioritising specimens for further downstream analyses. FUNDING: National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: allisonrs…
- Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
- Zalgen Labs, LLC, Frederick, MD, USA.
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA; Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
- Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Scripps Research
Zitieren
APA
Smither, A. R., Koninga, J., Kanneh, F. B., Foday, M., Boisen, M. L., Bond, N. G., Momoh, M., Sandi, J. D., Kanneh, L., Alhasan, F., Kanneh, I. M., Yillah, M. S., Grant, D. S., Bush, D. J., Nelson, D. K. S., Cruz, K. M., Klitting, R., Pauthner, M. G., Andersen, K. G., …, & Garry, R. F. (2025). Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101188
Vancouver
Smither AR, Koninga J, Kanneh FB, Foday M, Boisen ML, Bond NG, et al. Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study. The Lancet Microbe. 2025. doi:10.1016/j.lanmic.2025.101188
BibTeX
@article{Smither2025,
author = {Smither, Allison R and Koninga, James and Kanneh, Franklyn B and Foday, Momoh and Boisen, Matthew L and Bond, Nell G and Momoh, Mambu and Sandi, John D and Kanneh, Lansana and Alhasan, Foday and Kanneh, Ibrahim M and Yillah, Mohamed S and Grant, Donald S and Bush, Duane J and Nelson, Diana K S and Cruz, Kaitlin M and Klitting, Raphaëlle and Pauthner, Matthias G and Andersen, Kristian G and Shaffer, Jeffrey G and Branco, Luis M and Cross, Robert W and Schieffelin, John S and Garry, Robert F},
title = {Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study},
journal = {The Lancet Microbe},
year = {2025},
doi = {10.1016/j.lanmic.2025.101188}
}
EUVIMED